Sep 08, 2025 11:00
ABP - Abpro Holdings, Inc Common Stock
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 6.37 0.49 (7.61%) | 0.0 (0.0%) | -0.01 (-0.15%) | 0.21 (3.08%) | --- | 0.49 (7.61%) | --- | --- |
Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.
Market Period:
Market
Earnings & Ratios
- Basic EPS:
- -0.08
- Diluted EPS:
- -0.08
- Basic P/E:
- -85.6875
- Diluted P/E:
- -85.6875
- RSI(14) 1m:
- 55.14
- VWAP:
- 6.83
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|
Related News
Apr 27, 2025 18:00
Mar 10, 2025 22:34